Published in Am J Pathol on April 01, 1989
Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A (1990) 2.90
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol (1992) 2.61
Review: assessment of cell proliferation in histological material. J Clin Pathol (1990) 2.41
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat (2013) 2.26
Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A (1996) 2.06
Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol (1996) 2.04
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol (1992) 1.86
Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol (1990) 1.67
Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol (1991) 1.63
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J Virol (1996) 1.57
The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol (1995) 1.37
Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol (1991) 1.31
Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. Am J Pathol (2001) 1.30
Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer (1995) 1.26
Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development. Am J Pathol (1995) 1.21
Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol (1993) 1.20
Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol (1992) 1.18
Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol (1990) 1.14
Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (1991) 1.14
Distribution of the stem cells (neoblasts) in the planarian Dugesia japonica. Dev Genes Evol (2005) 1.13
Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium. Gut (1993) 1.12
Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. Am J Pathol (1991) 1.08
Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol (1992) 1.05
Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest (1993) 1.04
Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. Biomacromolecules (2009) 1.04
Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol (1993) 1.04
Transplant arteriosclerosis in a rat aortic model. Am J Pathol (1992) 1.03
Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol (1992) 1.00
Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics. Am J Pathol (1990) 0.99
Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde. Am J Pathol (1992) 0.97
Monoclonal antibody JC1: new reagent for studying cell proliferation. J Clin Pathol (1992) 0.93
Mechanical compression of articular cartilage induces chondrocyte proliferation and inhibits proteoglycan synthesis by activation of the ERK pathway: implications for tissue engineering and regenerative medicine. J Tissue Eng Regen Med (2009) 0.92
Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer (1994) 0.92
Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ Health Perspect (1993) 0.91
Quantitation of G0 and G1 phase cells in primary carcinomas. Antibody to M1 subunit of ribonucleotide reductase shows G1 phase restriction point block. J Clin Invest (1991) 0.91
Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers. HPB (Oxford) (2004) 0.88
Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Am J Pathol (1992) 0.88
Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticles. World J Gastroenterol (1999) 0.87
MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol (1994) 0.87
Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Br J Cancer (2000) 0.87
Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity. J Clin Pathol (1997) 0.86
Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis. Prostate (2009) 0.86
Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles. J Clin Pathol (1993) 0.84
Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Acta Neuropathol (1994) 0.84
Clinical and experimental study of therapeutic effect of Weixibaonizhuan pills on gastric precancerous lesions. World J Gastroenterol (1998) 0.84
Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol (1993) 0.83
Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma. J Clin Pathol (1993) 0.82
Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. Environ Health Perspect (1993) 0.81
Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer? Br J Cancer (1995) 0.81
Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol (1996) 0.80
PCNA expression in cutaneous keratinous neoplasms and verruca vulgaris. Am J Pathol (1992) 0.80
Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity. Am J Pathol (1992) 0.80
The angiopoietin/Tie2 axis mediates malignant pleural effusion formation. Neoplasia (2009) 0.80
Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens. Acta Neuropathol (1993) 0.80
Chemopreventive effects of Strobilanthes crispus leaf extract on azoxymethane-induced aberrant crypt foci in rat colon. Sci Rep (2015) 0.79
Effect of granulocyte-macrophage colony-stimulating factor on hepatic regeneration after 70% hepatectomy in normal and cirrhotic rats. HPB (Oxford) (2002) 0.79
Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Metastasis (1998) 0.78
Signaling from fibroblast growth factor receptor 2 in immature hematopoietic cells facilitates donor hematopoiesis after intra-bone marrow-bone marrow transplantation. Stem Cells Dev (2010) 0.78
Capacity for epithelial differentiation in synovial sarcoma: analysis of a new human cell line. J Clin Pathol (2000) 0.77
Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus. J Virol (2002) 0.77
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients. Oncol Lett (2015) 0.76
A comparative study of cell proliferation markers in breast carcinomas. Clin Mol Pathol (1995) 0.76
Analysis of proliferating cell nuclear antigen expression aids histological diagnosis and is predictive of progression of human cardiac allograft rejection. Am J Pathol (1994) 0.76
The change of proliferating cell nuclear antigen and apoptosis of the MM46 mammary cancer cells of the mouse after single high-dose irradiation. Med Mol Morphol (2005) 0.75
Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure. World J Gastroenterol (2005) 0.75
Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index. Arch Dermatol Res (1992) 0.75
Detecting proliferating cell nuclear antigen in archival rodent tissues. Environ Health Perspect (1993) 0.75
Nuclear translocation of nuclear factor Kappa B in first trimester deciduas and chorionic villi in early spontaneous miscarriage women. Int J Mol Sci (2010) 0.75
Biological indices in the assessment of breast cancer. Clin Mol Pathol (1995) 0.75
Immunohistochemical study of p53 and proliferating cell nuclear antigen expression in odontogenic keratocyst and periapical cyst. J Pharm Bioallied Sci (2014) 0.75
Effects of body-resistance strengthening and tumor-suppressing granules on immune adhesion function of red blood cells and expression of metastasis protein CD44 in tumor cells of patients with esophageal carcinoma. World J Gastroenterol (2007) 0.75
Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts. Dig Dis Sci (1999) 0.75
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 17.76
Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature (1987) 8.28
Autoantibody to a nuclear antigen in proliferating cells. J Immunol (1978) 4.36
Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem (1982) 3.88
Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A (1985) 3.62
A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol (1980) 3.50
Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol (1974) 3.09
Preparation and preliminary characterization of monoclonal antibodies against human DNA polymerase alpha. J Biol Chem (1982) 2.89
A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med (1981) 2.82
A rapid single step staining technique for DNA analysis by flow microfluorimetry. J Histochem Cytochem (1980) 2.76
Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science (1988) 2.74
Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol (1984) 2.42
Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res (1987) 2.13
Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods (1988) 2.07
The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol (1988) 2.06
Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med (1987) 1.84
Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res (1984) 1.79
Preparation of tissues for DNA flow cytometric analysis. Cytometry (1980) 1.60
Improved immunohistochemical localization of tissue antigens using modified methacarn fixation. J Histochem Cytochem (1985) 1.32
Monoclonal antibodies against mammalian ribonucleotide reductase. Acta Chem Scand B (1982) 1.08
Immunocytochemical characterization of a monoclonal antibody that recognizes mitosing cells. Am J Pathol (1985) 0.90
Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody. J Natl Cancer Inst (1987) 0.89
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet (1997) 4.72
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol (1986) 4.51
Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol (1991) 4.48
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation (1994) 4.32
Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol (1995) 3.37
Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science (1990) 3.27
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol (1999) 3.04
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol (2000) 2.53
Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies. J Cell Biol (1982) 2.45
Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol (1984) 2.42
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27
Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol (1986) 2.26
Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem (1997) 1.99
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol (1989) 1.87
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol (1999) 1.77
Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene (1999) 1.73
PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell (1991) 1.67
Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. Am J Clin Pathol (1989) 1.65
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 1.63
Thrombospondin in early human wound tissue. J Invest Dermatol (1987) 1.62
Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb (1992) 1.59
HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol (1987) 1.58
Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol (1992) 1.57
Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem (1995) 1.55
Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol (2000) 1.52
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol (2001) 1.51
Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet (1996) 1.50
Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am J Clin Pathol (1985) 1.50
Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing? Breast Cancer Res Treat (2011) 1.47
Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int (1992) 1.46
Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem (1999) 1.44
Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol (2000) 1.43
Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol (1985) 1.40
Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol (1999) 1.38
Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol (1998) 1.38
Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med (2001) 1.37
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc Natl Acad Sci U S A (1997) 1.35
Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol (2000) 1.34
P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol (2002) 1.33
Atheroma: the artery wall and the environment. Int Rev Exp Pathol (1980) 1.30
Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. Cancer Res (1995) 1.29
The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod Pathol (1991) 1.28
Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol (1993) 1.20
Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol (2001) 1.19
The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med (1999) 1.18
Cadaver middle ears as models for living ears: comparisons of middle ear input immittance. Ann Otol Rhinol Laryngol (1990) 1.18
Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol (1992) 1.18
Characterization of two monoclonal antibodies to human epidermal keratohyalin: reactivity with filaggrin and related proteins. J Invest Dermatol (1987) 1.17
Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins. Lab Invest (1984) 1.17
PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem (1991) 1.15
P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol (2004) 1.13
Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol (1996) 1.12
Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg (2001) 1.12
Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med (2000) 1.11
Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol (1992) 1.10
Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem (1992) 1.08
Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg (2000) 1.06
Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol (1992) 1.05
Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J Toxicol Environ Health (1981) 1.05
Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications. Am J Surg (1986) 1.04
Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol (1989) 1.04
Indications and complications of medicinal leech therapy. J Am Acad Dermatol (1995) 1.03
Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. Mod Pathol (1996) 1.03
Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer. Gynecol Oncol (2000) 1.01
Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol (1998) 1.01
Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Differ (1992) 1.00
Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol (1992) 1.00
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. Am J Pathol (1988) 1.00
Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 0.99
Cell cycle progression in gentamicin-damaged avian cochleas. J Neurosci (1995) 0.99
Cell proliferation after balloon injury of iliac arteries in the cholesterol-fed New Zealand White rabbit. Arterioscler Thromb (1994) 0.98
Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Virchows Arch (1999) 0.97
The fibroblast-like nature of myofibroblasts. Exp Mol Pathol (1988) 0.97
Macrophage and microglia-like cells in the avian inner ear. J Comp Neurol (1998) 0.97
A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope (1998) 0.97
Detection of cell proliferation in tissue sections. Braz J Med Biol Res (1993) 0.97
Coexpression of intermediate filaments in human epithelial neoplasms. Ultrastruct Pathol (1985) 0.96
CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood (1985) 0.96
A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue. Am J Clin Pathol (1989) 0.96
Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol (1999) 0.95
Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer (1989) 0.94
Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch (1995) 0.93
Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer. Head Neck (1997) 0.93
Identification of hair cell progenitors and intermitotic migration of their nuclei in the normal and regenerating avian inner ear. J Neurosci (1994) 0.93
Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol (1987) 0.92
Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections. Cancer (1988) 0.92
Overexpression of p53 in head and neck cancer. Head Neck (1993) 0.91
Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. Lab Invest (1991) 0.91
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol (2001) 0.91
Metabolism of very-low-density lipoprotein triglyceride by human placental cells: the role of lipoprotein lipase. Metabolism (1992) 0.91
Activation of B lymphocyte maturation by a human follicular dendritic cell line, FDC-1. J Immunol (1995) 0.90